Last reviewed · How we verify

liraglutide [3H]

Novo Nordisk A/S · Phase 1 active Small molecule

At a glance

Generic nameliraglutide [3H]
Also known as[3H]-liraglutide
SponsorNovo Nordisk A/S
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: